News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No major headlines published in the past hour across markets, economy, global events, or politics.
  • Markets lacked fresh catalysts, resulting in subdued trading activity this hour.
  • No central bank comments or macro data releases reported this hour.
  • No significant corporate earnings or M&A announcements surfaced this hour.
  • No geopolitical developments or notable policy moves reported this hour.
  • Upcoming scheduled data and market opens are the next potential catalysts.

Latest Articles

All In FutureTech Alliance Inc. Launches New Digital Platform for Consumers and Businesses, Advancing Its AI-Enabled Global Services Strategy

All In FutureTech Alliance Inc. Launches New Digital Platform for Consumers and Businesses, Advancing Its AI-Enabled Global Services Strategy

All In FutureTech Alliance Inc. announced the launch of its AIFA Digital Service Platform, a bilingual AI-centered content and education hub designed to build long-term user engagement and progressively connect users to its education, workforce development, and global business services. The platform supports a dual digital strategy with the corpora…

MiNK Therapeutics to Present Data on Treatment-Resistant Colorectal Cancer and Clearance of Senescent Tumor Cells and Fibroblasts at SITC 2026

MiNK Therapeutics to Present Data on Treatment-Resistant Colorectal Cancer and Clearance of Senescent Tumor Cells and Fibroblasts at SITC 2026

MiNK Therapeutics announced new data presentations on their allogeneic invariant natural killer T (iNKT) cell therapies, including agenT-797 and MiNK-215, showing potential efficacy against checkpoint inhibitor-resistant colorectal cancer liver metastases and senescent tumor cells and fibroblasts. The data support ongoing clinical trials and highli…

Candel Therapeutics to Present at the SITC 2026 Annual Meeting

Candel Therapeutics to Present at the SITC 2026 Annual Meeting

Candel Therapeutics announced it will present promising clinical and mechanistic data from its lead immunotherapy candidates, aglatimagene besadenovec and linoserpaturev, at the SITC 41st Annual Meeting. The presentations highlight immune activation and improved survival in patients with progressive non-small cell lung cancer (NSCLC) despite prior …

ProKidney Announces Eight Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2026

ProKidney Announces Eight Abstracts Selected for Presentation at the American Society of Nephrology’s Kidney Week 2026

ProKidney Corp., a clinical-stage biotechnology company focused on chronic kidney disease (CKD), announced it will present eight abstracts at the American Society of Nephrology's Kidney Week 2026. The presentations highlight translational and clinical data supporting the multifactorial mechanism of their lead cell therapy candidate, rilparencel, wh…

Chicago wheat gains on Saudi tender; dollar keeps upside muted

Chicago wheat gains on Saudi tender; dollar keeps upside muted

Chicago Board of Trade wheat futures rose for a second day as a large Saudi Arabian import tender improved demand sentiment. Gains were capped by a strong dollar, while corn and soybeans moved lower on supply and harvest developments. Market participants are also watching upcoming U.S. jobs data for clues on interest rate direction.

Micron: Buy the Buyback, Sit Through Slower Content Growth

Micron: Buy the Buyback, Sit Through Slower Content Growth

Micron just reported blockbuster Q4 results and fat guidance, but we think the smartest near-term trade is to own the stock to capture continued pricing tailwinds and an accelerated capital-return program while monitoring content growth metrics. Entry $1109.73, target $1350.00, stop $980.00; swing trade (45 trading days) with the option to convert …

Yen Strengthens on Hot Tokyo Inflation as Dollar Pauses Ahead of US Payrolls

Yen Strengthens on Hot Tokyo Inflation as Dollar Pauses Ahead of US Payrolls

The dollar eased modestly on Friday after expectations of weaker-than-anticipated US payrolls reduced near-term rate-hike anxiety. A surprise rise in Tokyo consumer prices lifted the Japanese yen and supported bets on further Bank of Japan tightening, while a sharp jump in euro zone headline inflation maintained pressure on the European Central Ban…

Global Bond Markets React to Weaker U.S. Jobs Data; French Yields Hit 2002 Highs as Bunds Slide to One-Week Lows

Global Bond Markets React to Weaker U.S. Jobs Data; French Yields Hit 2002 Highs as Bunds Slide to One-Week Lows

U.S. Treasury yields shifted after a much softer-than-expected September jobs report, with intermediate maturities rallying as markets dialed back expectations for near-term Federal Reserve tightening. French 10-year yields hovered near levels last seen in 2002 amid investor concern over Paris's budget plans, while German 10-year Bunds fell to one-…

StoneX Group Inc. Acquires Integra Trading S.A.S., Establishing a Colombian Coffee Origination and Processing Platform

StoneX Group Inc. Acquires Integra Trading S.A.S., Establishing a Colombian Coffee Origination and Processing Platform

StoneX Group Inc. has signed a definitive agreement to acquire Integra Trading S.A.S., a Colombian coffee trading, exporting, and processing company. The acquisition, conducted through StoneX's Swiss trading entity, will enhance StoneX's physical commodities business by increasing its direct origination and processing footprint in Colombia, improvi…

Liberty Defense and Wadsworth Solutions Announce Sale of HEXWAVE™ Systems to Cleveland Hopkins International Airport

Liberty Defense and Wadsworth Solutions Announce Sale of HEXWAVE™ Systems to Cleveland Hopkins International Airport

Liberty Defense Holdings Ltd. announced that Cleveland Hopkins International Airport will deploy two of its HEXWAVE systems to enhance the Aviation Worker Screening program. The AI-powered HEXWAVE system detects metallic and non-metallic threats using advanced millimeter wave technology and 3D imaging, providing comprehensive security screening. Wa…

Cycurion Regains Compliance with Nasdaq Bid Price Requirement

Cycurion Regains Compliance with Nasdaq Bid Price Requirement

Cycurion, Inc., a cybersecurity and AI solutions provider, announced it has regained compliance with Nasdaq's minimum bid price requirement following a 1-for-8 reverse stock split. The company’s stock has remained above the $1.00 threshold for over 10 consecutive trading days, preventing delisting and allowing continued trading under the ticker CYC…

Ruanyun Announces Preliminary Unaudited First-Half Fiscal 2027 Revenue in the Range of US$9.3 Million to US$9.5 Million

Ruanyun Announces Preliminary Unaudited First-Half Fiscal 2027 Revenue in the Range of US$9.3 Million to US$9.5 Million

Ruanyun Edai Technology Inc. expects its preliminary unaudited revenue for the first half of fiscal 2027 to be between $9.3 million and $9.5 million, significantly increasing from $0.37 million in the same period last year. This growth is primarily fueled by its Smart Campus Services business launched in September 2025, which accounts for over half…

SCIENTURE Announces Arbli™ Added to Formularies at Three Leading U.S. Pediatric Academic Medical Centers and Hospitals

SCIENTURE Announces Arbli™ Added to Formularies at Three Leading U.S. Pediatric Academic Medical Centers and Hospitals

Scienture Holdings, Inc. announced that its proprietary oral suspension formulation of losartan, Arbli™, has been added to the formularies of three prominent U.S. pediatric academic medical centers. This milestone enhances Arbli's presence in the pediatric healthcare market. The product addresses a significant $219 million U.S. losartan market by o…

Century Therapeutics' CNTY-813 Demonstrates Continued Advancement Toward the Clinic Via Nonclinical Data Presented at EASD 2026

Century Therapeutics' CNTY-813 Demonstrates Continued Advancement Toward the Clinic Via Nonclinical Data Presented at EASD 2026

Century Therapeutics announced nonclinical data demonstrating effective glycemic control, scalable manufacturing, and successful engraftment of their iPSC-derived islet replacement therapy, CNTY-813. The company is on track to submit an IND in Q4 2026 and anticipates initial clinical data in the second half of 2027, highlighting advancements toward…

Autonomix Medical Strengthens Patent Protection for Platform Technology Enabling Precision Access, Treatment Delivery and Procedural Validation

Autonomix Medical Strengthens Patent Protection for Platform Technology Enabling Precision Access, Treatment Delivery and Procedural Validation

Autonomix Medical announced issuance of Canadian Patent No. 3,183,802, which expands protection for their catheter-based transvascular intervention technologies that enable precise access, adaptive treatment delivery, and real-time procedural validation in nerve-targeted therapies. This patent complements existing U.S. and European patents, reinfor…

Thunder Bridge Capital Partners V, Ltd. Announces Separate Trading of its Class A Ordinary Shares and Warrants, Commencing October 5, 2026

Thunder Bridge Capital Partners V, Ltd. Announces Separate Trading of its Class A Ordinary Shares and Warrants, Commencing October 5, 2026

Thunder Bridge Capital Partners V, Ltd., a blank check company listed on Nasdaq, announced that holders of its units sold in the IPO can elect to separate and trade Class A ordinary shares and warrants individually starting October 5, 2026. The shares and warrants will trade under symbols TBCV and TBCVW respectively, while unseparated units will co…